Cancer (Oncology)
Cancer (Oncology)
Erlonat 150® Erlotinib Tablets
Erlotinib 150mg
- Composition
- Erlotinib 150mg
- Dosage form
- Tablet
- Pack size
- Bottle of 30 Tablet
- Manufacturer
- Natco
- Also known as
- Tarceva
Supplied against a valid prescription where required, in line with the regulations of the destination country.
Erlonat 150 mg contains erlotinib and is used to treat certain forms of non-small cell lung cancer and, in combination with other treatment, pancreatic cancer. It inhibits EGFR-related signalling pathways that help cancer cells grow and multiply.
As prescribed by a doctor. Dose and duration depend on the condition being treated and the patient. Do not change the dose without medical advice.
Side effects vary by patient. Common and serious side effects are listed in the pack insert. Contact a doctor if you have severe or unexpected symptoms.
Tell your doctor about other medicines you take, allergies, pregnancy or breastfeeding, and any liver or kidney conditions before use.
Store below 30 °C in a dry place, in the original pack, out of reach of children.
Need product documents?
Ask for the pack insert, batch details or a COA with your quote.
Ask on WhatsApp →Licensed wholesalerForm 20B & 21B, Delhi
Discreet packagingPlain outer box, no product labels
Worldwide shippingDirect to you or your customer
Related products
Cancer (Oncology)
Cancer (Oncology)
Tegonat 15® Tegafur, Gimeracil and Oteracil Capsules
Gimeracil 4.35mg+ Oteracil 11.8mg+ Tegafur 15mg
Tablet · Strip of 7 Capsule
Cancer (Oncology)
Cancer (Oncology)